Unlikely to cause harm — often a labeling or packaging issue.
Failed pH Specifications: Upward shift in the pH of the solution within the shelf life of the impacted lots.
| Brand name | METOPROLOL |
| Generic name | METOPROLOL TARTRATE |
| Active ingredient(s) | METOPROLOL TARTRATE |
| Distributed by / for | Claris Lifesciences, Inc., North Brunswick, NJ 08902. By: Claris Injectables Ltd., Gujarat, India |
| NDC | 36000-033-10 |
| Full product label | Metoprolol Tartrate Injection, USP, 5 mg/ 5 mL (1 mg/mL), 5 mL per sterile single use glass vial, Rx Only, Manufactured for: Claris Lifesciences, Inc., North Brunswick, NJ 08902. By: Claris Injectables Ltd., Gujarat, India. NDC: 36000-033-10 |
| Recalling firm | Baxter Healthcare Corporation |
| Distribution | Distributed nationwide in the USA and Puerto Rico |
| Quantity | 402,165 vials |
| Recall initiated | 2018-10-15 |
| Report date | 2018-11-14 |
| Recall completed | 2022-08-12 |
| Recall number | D-0222-2019 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Deerfield IL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗